Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Single Ascending Dose Trial in Patients With Type 2 Diabetes

This study has been terminated.
(Decision by Sponsor)
Information provided by (Responsible Party):
Amgen Identifier:
First received: September 28, 2011
Last updated: February 13, 2013
Last verified: February 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)